SHIRE INT LICENSING BV has a total of 57 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, Canada and China. Its main competitors in its focus markets pharmaceuticals, materials and metallurgy and machines are EXTEND BIOSCIENCES INC, SYNPHORA AB and ROYALTY PHARMA COLLECTION TRUST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Canada | 4 | |
#3 | China | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Brazil | 3 | |
#6 | Hong Kong | 3 | |
#7 | Israel | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Taiwan | 3 | |
#10 | WIPO (World Intellectual Property Organization) | 3 | |
#11 | Argentina | 2 | |
#12 | Malaysia | 2 | |
#13 | New Zealand | 2 | |
#14 | South Africa | 2 | |
#15 | Australia | 1 | |
#16 | Germany | 1 | |
#17 | EAPO (Eurasian Patent Organization) | 1 | |
#18 | United Kingdom | 1 | |
#19 | Hungary | 1 | |
#20 | Morocco | 1 | |
#21 | Mexico | 1 | |
#22 | Peru | 1 | |
#23 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Materials and metallurgy | |
#3 | Machines | |
#4 | Measurement | |
#5 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Hallenbeck Donald | 13 |
#2 | Bates Simon | 13 |
#3 | Webster Isobel | 11 |
#4 | Ferdinando Josephine Christine | 10 |
#5 | Davies Peter Neil | 10 |
#6 | Pratt Raymond Dennis | 9 |
#7 | Damment Stephen Jp | 7 |
#8 | Idzan Stefan R | 5 |
#9 | Fricker Simon P | 5 |
#10 | Abrams Michael J | 5 |
Publication | Filing date | Title |
---|---|---|
US2010015246A1 | Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases | |
HK1112052A1 | Assay for lanthanum hydroxy carbonate | |
US2007259052A1 | Assay for lanthanum hydroxycarbonate | |
EP1852695A1 | Assay for lanthanum hydroxy carbonate | |
US2007104799A1 | Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds | |
US2006121127A1 | Stabilized lanthanum carbonate compositions | |
MY128686A | Pharmaceutical composition containing selected lanthanum carbonate hydrates | |
GB9716879D0 | Treatment of attention deficit disorders |